None ...

The Russian state-sponsored APT28 threat group is using a custom variant of the open-source Covenant post-exploitation framework for long-term espionage operations.

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access scheme ...

Last year, we brought you a story about the BhangmeterV2, an internet-of-things nuclear war monitor. With a cold-war-era ...